Hangzhou Biotest Biotech Co.,Ltd.
Shanghai Stock Exchange 688767.SS
Hangzhou Biotest Biotech Co.,Ltd. Goodwill for the year ending December 31, 2023: USD 0.00
-
Hangzhou Biotest Biotech Co.,Ltd. Goodwill for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
-
Hangzhou Biotest Biotech Co.,Ltd. Goodwill for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
-
Hangzhou Biotest Biotech Co.,Ltd. Goodwill for the year ending December 31, 2020 was USD 0.00, a 0.00% change year over year.
-
Hangzhou Biotest Biotech Co.,Ltd. Goodwill for the year ending December 31, 2019 was USD 0.00, a 0.00% change year over year.
| Date | Goodwill | Total Assets | Current Liabilities | Total Non-Current Liabilities |
|---|
Don’t Miss A Beat
| CEO | Mr. Shujiang Wu |
| IPO Date | Sept. 8, 2021 |
| Location | China |
| Headquarters | No.17, Futai Road |
| Employees | 629 |
| Sector | Healthcare |
| Industries | |
Hangzhou Biotest Biotech Co., LTD. engages in the research and development, manufacture, sale, and service of in vitro diagnostic assays and reagents, and equipment in China and Internationally. It offers medical test products for fertility health, oncology, cardiology, inflammation, biochemistry, and various infectious diseases, as well as COVID-19 rapid tests, such as antibody and antigen testing kits; and urine and saliva drug, hair drug, and vitamin D rapid testing kits. The company also provides immunochromatography readers and fluorescence immunoassay quantitative analyzers. Hangzhou Biotest Biotech Co., LTD. was founded in 2008 and is based in Hangzhou, China.
Past 5 years
StockViz Staff
February 2, 2025
Any question? Send us an email